Healthcare Analytics Platform: DOS Delivers the 7 Essential Components

| January 7, 2018

article image
Population health, value-based care, decreasing revenues, and increasing costs are just a few of the pivotal issues challenging healthcare IT leaders today. Among other requirements, these issues call for large amounts of data, real-time data access, scalable analytics platforms, and systems interoperability. Healthcare IT must address all these issues, and more, even as technology becomes obsolete at an exponentially increasing pace.

Spotlight

T2 Healthcare

T2 Healthcare are a healthcare recruitment company, who help healthcare professionals secure permanent jobs across the UK. We have a broad range of job opportunities covering all specialities, meaning we can tailor your needs. Due to our determination and resilience, our services stands out from the rest, whether you are a client in need of staff or seeking employment we have the resources to meet your demands.

OTHER ARTICLES

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | April 1, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | April 1, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | April 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Spotlight

T2 Healthcare

T2 Healthcare are a healthcare recruitment company, who help healthcare professionals secure permanent jobs across the UK. We have a broad range of job opportunities covering all specialities, meaning we can tailor your needs. Due to our determination and resilience, our services stands out from the rest, whether you are a client in need of staff or seeking employment we have the resources to meet your demands.

Events